New Nordic Healthbrands AB (publ) Interim Report Q2 January - June 2026
The second quarter (April 1, 2026 - June 30, 2026) • The Group's net sales increased by 14.5% during the quarter to SEK 163.8 million (SEK 143.0 million). In local currencies, the increase was 16.3%. • The gross margin decreased to 63.5% (64.8%), while gross profit increased to SEK 104.1 million (SEK 92.6 million). • Operating profit (EBIT) improved to SEK 9.0 million (SEK 3.8 million). • Net profit for the period improved to SEK 7.3 million (SEK 2.1 million), corresponding to SEK 1.18 (SEK 0.34) per share*. • Cash flow from operating activities amounted to SEK 5.3 million (SEK 3.5 million). The first half of the year (January 1, 2026 - June 30, 2026) • Group's net sales increased by 3.3% during the first six months of the year to SEK 296.2 million (SEK 286.8 million). In local currencies, the increase was 7.7%. • The gross margin decreased to 63.0% (64.7%), while gross profit amounted to SEK 186.7 million (SEK 185.5 million). • Operating profit (EBIT) amounted to SEK 7.5 million (SEK 8.7 million). • Net profit for the period decreased to SEK 4.4 million (SEK 4.8 million), corresponding to SEK 0.72 (SEK 0.77) per share*. • Cash flow from operating activities amounted to negative SEK 5.7 million (negative SEK 2.8 million). * There are no dilution effects